Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)–an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT) (2019) Kansagra AJ, Frey NV, Bar M, Laetsch TW, Carpenter PA, Savani BN, Heslop HE, et al. Journal article The use of bispecific antibodies to optimize the outcome of patients with acute leukemia, lymphoma and multiple myeloma after SCT (2019) Einsele H, Rasche L, Topp MS, Kortuem KM, Duell J Journal article Non-invasive diagnosis of acute intestinal graft-versus-host disease by a new scoring system using ultrasound morphology, compound elastography, and contrast-enhanced ultrasound (2019) Weber D, Weber M, Hippe K, Ghimire S, Wolff D, Hahn J, Evert M, et al. Journal article Haploidentical transplant with post-transplant cyclophosphamide for T-cell acute lymphoblastic leukemia: Outcome strongly correlates with disease status; a report from the EBMT acute leukemia working party (2019) Bazarbachi A, Labopin M, Angelucci E, Gulbas Z, Ozdogu H, Arat M, De Rosa L, et al. Conference contribution Second allogeneic stem cell transplantation in acute lymphoblastic leukemia patients in second complete remission or relapse: A study on behalf of the ALWP / EBMT (2019) Nagler A, Labopin M, Finke J, Brecht A, Schanz U, Niittyvuopio R, Neubauer A, et al. Conference contribution Single cell identification of defined ebv epitope-specific TCR alpha beta pairs for adoptive T cell transfer against EBV infection and EBV-associated malignancies (2019) Cobo MFL, Pircher C, Dietze K, Kammertons T, Gary R, Moosmann A, Mautner J, et al. Conference contribution Leukemia control after allogeneic hematopoietic cell transplantation through ex vivo expanded invariant natural killer T cells from donor lymphocyte infusions (DLI-INKTS) (2019) Jahnke S, Schmid H, Secker KA, Duerr-Stoerzer S, Keppeler H, Schumm M, Handgretinger R, et al. Conference contribution Presence of centromeric but absence of telomeric group B KIR haplotypes in stem cell donors improve leukaemia control after HSCT for childhood ALL (2019) Babor F, Peters C, Manser AR, Glogova E, Sauer M, Pötschger U, Ahlmann M, et al. Journal article Intestinal graft-versus-host disease is driven by BATF-dependent IL-7R(hi)GM-CSF+ T cells (2018) Ullrich E, Abendroth B, Rothamer J, Huber C, Buettner-Herold M, Kitowski V, Vogler T, et al. Conference contribution Depletion of donor-specific anti-HLA A2 alloantibodies in a hematopoietic cell transplant recipient using directed mismatched platelet transfusions (2018) Spriewald BM, Bach C, Zingsem J, Strobel J, Winkler J, Mackensen A, Rösler W Journal article